# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000629
Filing Date
2025-04-14
Accepted
2025-04-14 14:09:39
Documents
71
Period of Report
2025-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | lxrp_10q.htm iXBRL | 10-Q | 952026
2 | FORM OF DIRECTOR SERVICES AGREEMENT | lxrp_ex103.htm | EX-10.3 | 33917
3 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 12037
4 | CERTIFICATION | lxrp_ex312.htm | EX-31.2 | 12548
5 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 6433
6 | CERTIFICATION | lxrp_ex322.htm | EX-32.2 | 6573
| Complete submission text file | 0001640334-25-000629.txt |  | 5110785

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20250228.xsd | EX-101.SCH | 50974
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20250228_lab.xml | EX-101.LAB | 289402
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20250228_cal.xml | EX-101.CAL | 46567
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20250228_pre.xml | EX-101.PRE | 242735
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20250228_def.xml | EX-101.DEF | 126160
74 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10q_htm.xml | XML | 836203

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 25835417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)